Premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) are well-documented disorders causing significant morbidity in the female population. Treatments prescribed do not necessarily reflect proven clinical effectiveness. A recent systematic review from the Exeter Department of Complementary Medicine failed to endorse complementary therapies as a whole for treatment of PMS. Howev...

background: premenstrual syndrome (pms) is a combination of physical, psychological, or behavioral changes in the late secretary phase of menstrual cycle and interferes with interpersonal relationships or activities.the purpose was to assess the effects of 8 weeks of regular aerobic exercise on pms in non-athlete girls. materials and methods: this quasi-experimental study was conducted on 40 no...

BACKGROUND Premenstrual Syndrome (PMS) is the term for severe symptoms experienced by about 5% of menstruating women up to two weeks before their menstrual periods, but not at other times. Treatment with progesterone may restore a deficiency, or balance the level of progesterone with other menstrual hormones. Progesterone therapy may reduce the effects of falling progesterone levels on the brai...

marvelon®, a combined oral contraceptive, contains 30 μg ethinyl estradiol (ee) and 150 μg desogestrel (de), and has been shown to be a well-tolerated and effective combination that provides high contraceptive reliability and good cycle control. however, its efficacy has not been yet evaluated among iranian women. thus, the study aimed to determine the effect of oral contraceptive pill on treat...

Marvelon®, a combined oral contraceptive, contains 30 μg ethinyl estradiol (EE) and 150 μg desogestrel (DE), and has been shown to be a well-tolerated and effective combination that provides high contraceptive reliability and good cycle control. However, its efficacy has not been yet evaluated among Iranian women. Thus, the study aimed to determine the effect of oral contraceptive pill on treat...